The Future of Data-Driven Patient Support Is Now
The use of health data technologies and analytics in the life sciences industry continues to evolve, but many manufacturers are still crawling around in the dark. With limited in-person patient and provider-rep interactions, hubs that lack synergized technology and data are struggling to understand access and adherence barriers – and, most importantly, new and unexpected patient needs.
Despite best efforts, prescription rates continue to drop as newly launched products experience increased patient drop-off; and companies are struggling to support patient acquisition, retention and conversion.
In a new 60-minute virtual panel, PharmaVOICE Co-Founder and Editor Taren Grom interviews EVERSANA’s Maria Kirsch and Kevin O’Meara and Travere Therapeutics’ John Wiedemann to discuss how changing market dynamics are creating a need for next gen patient services.
In this one-hour virtual webinar, you’ll learn how to:
- Leverage innovative technology, such as advanced analytics and machine learning, to overcome access barriers;
- Personalize patient and HCP engagement; and
- Maximize outcomes throughout the patient journey and demonstrate therapeutic success.
EVERSANA employs a team of over 2500 professionals across 27 locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…